Several antibodies-based drugs for the treatment of patients with coronavirus may appear in Russia, tests of one drug will begin next fall, said Alexander Gintsburg, head of the Gamaleya Center. It was reported by RIA Novosti on Monday, December 28.
According to Gunzburg, the drug will be used as a dropper, and its effect is expected to appear in 7-10 days. The medicine will be many times more expensive than the vaccine, he said.
“Various technologies are used to obtain these antibodies, which is already a clinical drug. They have slightly different properties. You will never know in advance which property will be better and which drug will have advantages by which technology,”he said.
In response to a question about the possible risks of using the drug, the specialist noted that "this is what clinical trials are for."
The day before, The Guardian reported that trials of a new drug, Storm Chaser, had begun in London to obtain rapid immunity to coronavirus. According to the publication, the drug is already in the first phase of clinical trials on volunteers. The antibodies will be administered to volunteers in two stages.
